Maiken Nedergaard

This inventor holds 8 USPTO granted patents and 8 published patent applications and 3 EPO patents. Top assignees: University of Rochester, Cornell University, New York Medical College. Active years: 2004-2025.

USPTO Granted Patents = 8 (Patent Applications = 8)

% Patents Active = 62.5

EPO Patents = 3 (Patent Applications = 9)

Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 70(Granted Patents)

Location History:

South Salem, NY (US) (2004 - 2007)
Webster, NY (US) (2010 - 2023)

Company Filing History:

4 out of 994

University of Rochester

New York Medical College

patents

4. 1 out of 2,044

The State University of New York

patents

5. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12311035 - Glymphatic delivery by manipulating plasma osmolarity (2025-05-27),

2. 11690876 - Methods of treating neuropsychiatric disorders (2023-07-04),

3. 9901650 - Methods for evaluating brain-wide paravascular pathway for waste clearance function and methods for treating neurodegenerative disorders based thereon (2018-02-27),

4. 9616075 - [object Object] (2017-04-11),

5. 7923448 - Purine receptor inhibition as a therapeutic strategy in spinal cord and brain (2011-04-12),

6. 7829332 - Purines are self-renewal signals for neural stem cells, and purine receptor antagonists promote neuronal and glial differentiation therefrom (2010-11-09),

7. 7250394 - Treatment of glial tumors with glutamate antagonists (2007-07-31),

8. 6812027 - Discovery, localization, harvest, and propagation of an FGF2 and BDNF-responsive population of neural and neuronal progenitor cells in the adult human forebrain (2004-11-02),

Title: Maiken Nedergaard: Innovator in Neurobiology

Introduction

Maiken Nedergaard is a prominent inventor based in Webster, NY, renowned for her groundbreaking contributions to neurobiology. Having secured eight patents, she has made significant strides in understanding and treating neuropsychiatric disorders, paving the way for innovative therapies in the field.

Latest Patents

Among her latest inventions, Nedergaard's patent titled "Glymphatic delivery by manipulating plasma osmolarity" focuses on enhancing the delivery of therapeutic agents to the central nervous system. Additionally, she has developed methods for "treating neuropsychiatric disorders," which detail the administration of glial progenitor cells and potassium (K) channel activators. These methods aim to restore normal brain function and contribute to effective treatments for individuals suffering from neuropsychiatric conditions.

Career Highlights

Maiken Nedergaard has built a distinguished career marked by her association with prestigious institutions such as the University of Rochester and Cornell Research Foundation, Inc. Her work has significantly influenced the landscape of neurobiological research and has positioned her as a leader in her field.

Collaborations

Throughout her career, she has collaborated with esteemed colleagues such as Steven A. Goldman and Jeffrey J. Iliff. These partnerships have enabled her to expand her research horizons and enhance the impact of her innovative endeavors.

Conclusion

Maiken Nedergaard’s passion for discovery and her innovative patents contribute greatly to the advancement of neurobiology. Her ongoing research promises to deliver transformative solutions for neuropsychiatric disorders, exemplifying the vital role of inventors in shaping the future of science and medicine.